| Literature DB >> 31153722 |
Camila H Coelho1, Rino Rappuoli2, Peter J Hotez3, Patrick E Duffy4.
Abstract
Malaria kills more than 600 000 people yearly, mainly children, and eradication is a global priority. Malaria transmission-blocking vaccines are advancing in clinical trials, and strategies for their introduction must be prioritized among stakeholders and the vulnerable populations exposed to the disease. Published by Elsevier Ltd.Entities:
Keywords: low-income countries; malaria vaccines; transmission-blocking vaccines; vaccine introduction
Mesh:
Substances:
Year: 2019 PMID: 31153722 DOI: 10.1016/j.pt.2019.04.008
Source DB: PubMed Journal: Trends Parasitol ISSN: 1471-4922